Copyright © 2000 by the European Society of Cardiology.
Letters to the Editor
Nitric oxide synthase in CHF
Cardiac Medicine, National Heart and Lung Institute, London, U.K.
References
- Comini L, Bachetti T, Agnoletti L. Induction of functional inducible nitric oxide synthase in monocytes of patients with congestive heart failure. Link with tumour necrosis factor-alpha. Eur Heart J. 1999;20:15031513
[Abstract/Free Full Text] - Muller-Werdan U, Engelmann H, Werdan K. Cardiodepression by tumor necrosis factor-alpha. Eur Cytokine Netw. 1998;9:689691[Web of Science][Medline]
- Oral H, Dorn GW 2nd, Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte. J Biol Chem. 1997;272:48364842
[Abstract/Free Full Text] - Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest. 1993;92:23032312[Web of Science][Medline]
- Zell R, Geck P, Werdan K, Boekstegers P. TNF-alpha and IL-1 alpha inhibit both pyruvate dehydrogenase activity and mitochondrial function in cardiomyocytes: evidence for primary impairment of mitochondrial function. Mol Cell Biochem. 1997;177:6167[CrossRef][Web of Science][Medline]
- Muller-Werdan U, Schumann H, Loppnow H. Endotoxin and tumour necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles. J Mol Cell Cardiol. 1998;30:10271036[CrossRef][Web of Science][Medline]
- Comstock KL, Krown KA, Page MT. LPS-induced TNF-alpha release from and apotosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol. 1998;30:27612775[CrossRef][Web of Science][Medline]
- Krown KA, Page MT, Nguyen C. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 1996;98:28542865[Web of Science][Medline]
- Natoli G, Costanzo A, Guido F, Moretti F, Levrero M. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. Biochem Pharmacol. 1998;56:915920[CrossRef][Web of Science][Medline]
- Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol. 1998;274:R577595
- Oddis CV, Simmons RL, Hattler BG, Finkel MS. Chronotropic effects of cytokines and the nitric oxide synthase inhibitor, L-NMMA, on cardiac myocytes. Biochem Biophys Res Commun. 1994;205:992997[CrossRef][Web of Science][Medline]
- Roberts AB, Roche NS, Winokur TS, Burmester JK, Sporn MB. Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1. J Clin Invest. 1992;90:20562062[Web of Science][Medline]
- Werdan K, Muller-Werdan U. Elucidating molecular mechanisms of septic cardiomyopathythe cardiomyocyte model. Mol Cell Biochem. 1996;163:291303
- Reithmann C, Werdan K. Tumor necrosis factor alpha decreases inositol phosphate formation and phosphatidylinositol-bisphosphate (PIP2) synthesis in rat cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol. 1994;349:175182[Web of Science][Medline]
- Aggarwal BB, Eessalu TE, Hass PE. Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature. 19851986;318:665667
- Holtmann H, Wallach D. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. J Immunol. 1987;139:11611167[Abstract]
- Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 1986;95:99105[CrossRef][Web of Science][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||